Genmab A (GMAB) Operating Expenses (2018 - 2026)
Genmab A (GMAB) posted Operating Expenses of -$716.0 million for Q1 2026, up 56.74% on a QoQ basis from -$1.7 billion in Q3 2025, and down 35.86% year-over-year from -$1.1 billion in Q1 2025.
Genmab A (GMAB) Operating Expenses (2018 - 2026) Analysis & Trends
Genmab A's Operating Expenses history runs 6 years deep, the most recent figure standing at -$716.0 million for Q1 2026.
- Quarterly Operating Expenses fell 35.86% year-over-year to -$716.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 billion (down 11.96% YoY) and the FY2025 annual result came in at $2.7 billion, up 23.55% from the prior year.
- Operating Expenses was -$716.0 million for Q1 2026 at Genmab A, up from -$1.7 billion in the prior quarter.
- Across five years, Operating Expenses topped out at -$487.0 million in Q1 2024 and bottomed at -$1.7 billion in Q3 2025.
- A 3-year average of -$1.0 billion and a median of -$1.0 billion in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2025 — Operating Expenses fell 6.02% — and 2026, when it tumbled 35.86%.
- Genmab A's Operating Expenses stood at -$1.5 billion in 2024, then decreased by 7.75% to -$1.7 billion in 2025, then jumped by 56.74% to -$716.0 million in 2026.
- Business Quant data shows GMAB's Operating Expenses at -$716.0 million in Q1 2026, -$1.7 billion in Q3 2025, and -$1.1 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -716.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -716.00 Mn |
| Sep 30, 2025 | -1.66 Bn |
| Jun 30, 2025 | -1.09 Bn |
| Mar 31, 2025 | -527.00 Mn |
| Sep 30, 2024 | -1.54 Bn |
| Jun 30, 2024 | -1.03 Bn |
| Mar 31, 2024 | -487.00 Mn |
| Sep 30, 2020 | -866.00 |
| Dec 31, 2019 | -689.00 |
| Sep 30, 2019 | -689.11 Mn |
| Dec 31, 2018 | -398.42 Mn |